Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The recent launch event of the Experimental Medicine Industry Partnership was an exciting collaboration between industry representatives and researchers from the University of Oxford. During the event, a series of workshops were held to discuss opportunities, challenges, and future directions for the application of experimental medicine in psychiatric drug development.

Business Unity and connection partnership as ropes shaped as a circle in a group of diverse strings connected together shaped as a support symbol expressing the feeling of teamwork and togetherness.

Dr Susannah Murphy, Department of Psychiatry, University of Oxford, explains:

 

'The Experimental Medicine Industry Partnership (EMIP) is a fantastic opportunity for industry partners and researchers to work together to share expertise and maximise opportunities for developing improved psychiatric treatments. By offering tailored peer review and advice the EMIP will help to rapidly progress new treatments into clinical trials, bringing potential new, life changing treatments a step closer to improving the lives of patients.'

Professor Catherine Harmer, Department of Psychiatry, University of Oxford, said:

 

'It was fascinating to hear pressing questions from an industry perspective and to take part in discussions with other academics. The conversations have spearheaded many collaborations and have inspired us to develop our models in ways that can also work for industry and their requirements. I look forward to continued and future collaborations.'

50 representatives from 15 industry partners and 90 Oxford researchers with expertise in cognitive neuroscience, pharmacology treatment, lifestyle interventions, gut health and precision psychiatry, took part in the AIMday event in July 2021, . 

Read more about this and other topics discussed during the event

For more information about the Experimental Medicine and Industry Partnership (EMIP) 

An Academic Industry Meeting Day (AIMday) is an innovative networking event that allows organisations external to the University of Oxford to set the agenda and gain academic perspective on industry challenges. 

The event was developed through the National Institute for Health Research Oxford Health Biomedical Research Centre (a partnership between the University of Oxford and the Oxford Health NHS Foundation Trust).

NIHR OXFORD HEALTH BIOMEDICAL RESEARCH CENTRE NEWS

Please follow the link below to read the news on the NIHR BRC website.

Similar stories

Mindfulness for Teachers - "Finding Peace in a Frantic World"

A new research study involving more than 200 teachers from across the UK investigated how their experiences and levels of stress, mental health and burn out were impacted by either taught or self-taught mindfulness training.

New Research Highlights Importance of Early Years Development on Future Wellbeing

Oxford researchers involved nearly 4,000 children across the UK in three specially developed science lessons to educate pupils about brain development during early childhood. The SEEN (Secondary Education around Early Neurodevelopment) project was commissioned and funded by KindredSquared and is part of a wider drive to increase public understanding of how early experiences can shape the adults we become.

2021 Most Highly Cited Researchers

Four researchers in the Department of Psychiatry are in the Highly Cited Researcher 2021 list.

Oxfordshire Young People Involved in Childline Research Project

New research conducted by the Neuroscience, Ethics and Society group and NeurOX Young People’s Advisory Group in the Department of Psychiatry at the University of Oxford, and the NSPCC, has looked at how Childline’s message boards help support young people.

28th British Isles Research Workshop on Suicide and Self-Harm & Lancet Psychiatry Suicide Symposium

This year's annual meeting focused again on research related to the impact of the COVID-19 pandemic on suicide and self-harm. There was another session on online safety in the context of suicidal behaviour and the Online Safety Bill. Organised by the Centre for Suicide Research, University of Oxford, these virtual workshops for both senior and early career researchers from the UK and Ireland provide an important opportunity to share knowledge and discuss the latest research. This year there were also contributions from Australia and Denmark.

What is the Role of Science in Mental Health?

A new summary report, What science has shown can help young people with anxiety and depression - Identifying and reviewing the 'active ingredients' of effective interventions, from Wellcome has been published. It includes new research from Oxford University, which investigates the knowns and unknowns of SSRI treatment (antidepressant drugs) in young people with depression and anxiety.